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Abstract
Plaque rupture causes acute coronary syndromes and stroke. Intraplaque oxidized low density 
lipoprotein (oxLDL) is metabolically unstable and prone to induce rupture. We designed an 
intravascular ultrasound (IVUS)-guided electrochemical impedance spectroscopy (EIS) sensor to 
enhance the detection reproducibility of oxLDL-laden plaques. The flexible 2-point micro-
electrode array for EIS was affixed to an inflatable balloon anchored onto a co-axial double layer 
catheter (outer diameter = 2 mm). The mechanically scanning-driven IVUS transducer (45 MHz) 
was deployed through the inner catheter (diameter = 1.3 mm) to the acoustic impedance matched-
imaging window. Water filled the inner catheter to match acoustic impedance and air was pumped 
between the inner and outer catheters to inflate the balloon. The integrated EIS and IVUS sensor 
was deployed into the ex vivo aortas dissected from the fat-fed New Zealand White (NZW) rabbits 
(n=3 for fat-fed, n= 5 normal diet). IVUS imaging was able to guide the 2-point electrode to align 
with the plaque for EIS measurement upon balloon inflation. IVUS-guided EIS signal 
demonstrated reduced variability and increased reproducibility (p < 0.0001 for magnitude, p < 
0.05 for phase at < 15 kHz) as compared to EIS sensor alone (p < 0.07 for impedance, p < 0.4 for 
phase at < 15 kHz). Thus, we enhanced topographic and EIS detection of oxLDL-laden plaques 
via a catheter-based integrated sensor design to enhance clinical assessment for unstable plaque.
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1 Introduction
Plaque rupture is the primary mechanism underlying acute coronary syndromes and stroke 
[1–5]. Despite the advent of computed tomographic (CT) angiography, high resolution MRI 
[6], intravascular ultrasound (IVUS) [7, 8], near-infrared fluorescence [9], and time-resolved 
laser-induced fluorescence spectroscopy [10], real-time detection of the atherosclerotic 
lesions prone to rupture remains an unmet clinical challenge [11, 12]. In this context, we 
seek to establish an integration of sensing modalities, IVUS and electrochemical impedance 
spectroscopy (EIS) for detection of the metabolically unstable lesions.
Our laboratory has demonstrated that endoluminal EIS distinguishes pre-atherogenic lesions 
associated with oxidative stress in fat-fed New Zealand White (NZW) rabbits [13–17]. 
Specifically, vessel walls harboring oxidized low density lipoprotein (oxLDL) exhibit 
distinct EIS signals [17]. We revealed that oxLDL and foam cell infiltration in the 
subendothelial layer engendered an elevated frequency-dependent EIS by using concentric 
bipolar microelectrodes [17]. We validated specific electric elements to simulate working 
and counter electrodes at the electrode-endoluminal tissue interface [15]. We further 
established the application of EIS strategy to detect oxLDL-rich fibroatheroma using 
explants of human coronary, carotid, and femoral arteries [15]. The regions of elevated EIS 
correlated with intimal thickening detected via high-frequency (60 MHz) IVUS imaging and 
by prominent oxLDL staining [18].
In addition to the electrochemical (EIS) strategy, alternative techniques have been developed 
to assess the thin-cap fibroatheroma [5, 19, 20] and intraplaque angiogenesis [21–23] for 
plaque vulnerability. Integrated IVUS and optical coherence tomography (OCT) catheter 
was developed to acquire high resolution thin fibrous cap and the underlying necrotic core 
simultaneously [24]. Whereas the incremental imaging data helps determine the 
characteristics of plaque, the OCT technique is limited by the need for saline solution 
flushing [24]. Photoacoustics utilizes the high photo-absorption and thermal expansion of 
blood, and has been applied to visualize angiogenesis [25–27]. Intravascular photoacoustics 
enables to image vasa vasorum and intraplaque micro-vessel visualization [28–30]. 
However, the heat generated from thermal expansion poses an adverse effect on the 
vulnerable plaque [31]. Similar to OCT, saline solution flushing to remove red blood cells in 
aorta is essential [28]. The advent of near-infrared fluorescence (NIRF) provides cysteine 
protease activity as an indicator of inflammation [32], and the use of glucose analogue [18F]-
fluorodeoxyglucose (18FDG) reveals metabolic activity by positron emission tomography 
(PET) [33]. However, injection of contrast agents is required for NIRT and radioactive 
isotopes PET imaging. Acoustic angiography [34, 35] excites at fundamental frequency and 
detects super-harmonics of microbubble contrast agents [36, 37] that were carried to micro-
vessels by circulation. Dual frequency intravascular ultrasound transducers [38, 39] were 
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designed [40] to visualize the vasa vasorum and intraplaque vasculature. The acoustic 
angiography techniques benefited from large penetration depth and free of heating. 
Occlusion of blood flow followed by saline flushing is also indicated if the harmonic signal 
is highly scattered by microbubbles in aorta. The dual frequency IVUS also enabled to 
image the thin-cap fibroatheroma at the high frequency (30 MHz) and image the oxLDL at 
the low frequency (6.5 MHz) [38].
In this context, we seek to integrate both IVUS imaging and EIS measurements to 
characterize the metabolically active, albeit non-obstructive lesions when patients are 
undergoing diagnostic angiogram or primary coronary intervention. Rupture-prone plaques 
consist of oxLDL and necrotic core with low conductivity. When alternating current (AC) is 
applied to a plaque, the oxLDL-rich lesion is analogous to a capacitance component, 
exhibiting both elevated electrical impedance magnitude and negative phase. The divergence 
of electrical impedance between the oxLDL-laden plaque and healthy vessel provides a 
sensitive and specific assessment of atherosclerotic lesions. We developed a catheter-based 
2-point micro-electrode configuration for intravascular deployment in NZW rabbits [41]. An 
array of 2 flexible rectangular electrodes, 3 mm in length by 300 μm in width, and separated 
by 300 μm, was microfabricated and mounted on an inflatable balloon catheter for EIS 
measurement of oxLDL-rich lesions. Upon balloon inflation by air pressure, the 2-point 
electrode array conformed to the arterial wall to with alternating current (AC) excitation. 
The frequency sweep from 100 – Hz 300 kHz generated distinct changes in both impedance 
(Ω) and phase (ϕ) in relation to varying degrees of intraplaque oxLDL burden in the aorta 
[41].
IVUS imaging visualizes the endoluminal surface, eccentricity of the plaque, intraplaque 
echogenicity and arterial wall thickness [42]. The mechanically scanning IVUS transducer 
(20~45 MHz) or the radial array transducer (10~20 MHz), transmitting and receiving the 
high frequency ultrasonic waves, is capable of delineating the cross-sectional anatomy of 
coronary artery wall in real time with 70 to 200 μm axial resolution, 200 to 400 μm lateral 
resolution, and 5 to 10 mm imaging depth [43, 44]. For these advantages, simultaneous 
IVUS-guided EIS measurement enabled precise alignment of the visualized plaques with the 
balloon-inflatable EIS sensor; thereby, providing both topological and biochemical 
information of the plaque (Figure 1). We performed ex vivo assessment of NZW rabbit 
aortas after 8 weeks of high-fat diet, and demonstrated significant reproducible 
measurements in both impedance and phase (p-value < 0.05) via IVUS-guided EIS 
assessment. Thus, our integrated sensor design enhanced IVUS-visualized plaques and EIS-
detected oxLDL to assess metabolically unstable plaques.
To enhance the specificity, we have hereby established a dual sensing modalities, integrating 
ultrasound (IVUS) and electrochemical impedance (EIS) for detection of the mechanically 
and metabolically unstable lesions (Table 1). The integrated sensing modalities allow initial 
identification and visualization by IVUS, then electrochemical characterization by EIS. 
Unlike the aforementioned techniques, the IVUS-guided EIS assesses the biochemical 
property of plaques without the need to perform occlusion flushing.
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2 Methods
2.1 Integrated sensor design
Built on our prior intravascular techniques [18, 45], the catheter-based dual sensors 
cannulate through aortas to reach the lesion sites for detection (Figure 1A). While 
advancing, the balloon (Advanced Polymers, Salem, NH, USA) is deflated (inset of Figure 
1A) and the whole diameter of the sensor is 2.3 mm. When the sensor reaches the detecting 
sites, the IVUS transducer scans the section of aorta through the imaging window by 
rotating and pulling-back. In case lesion sites are detected, the whole sensor is further 
advanced and rotated to align the EIS sensor at the lesion sites. Air is then pumped though 
the outer catheter to inflate the balloon, allowing the 2-point electrode to make contract with 
the lesions. EIS measurement is performed and the impedance characteristics indicate the 
presence or absence of intraplaque lipid (oxLDL). These sequential steps effectively 
minimized the interference between the EIS sensor the IVUS acoustic pathway.
Performance of the integrated sensor was established by the IVUS-visualized endolumenal 
plaque and EIS-detected intraplaque oxLDL (Figure 1B). The two sensors were 
intravascularly deployed by two layers of catheters bonded together at the end of the outer 
layer. The 45 MHz IVUS transducer [46] was enclosed in the inner catheter with an imaging 
window while the EIS sensor was affixed to a balloon that was anchored on the outer 
catheter. The inner catheter was designed to be longer than the outer catheter by ~2 – 10 cm 
for the IVUS imaging window.
The IVUS imaging process required the acoustic wave to reach aorta walls and echo back to 
the IVUS transducer. For this reason, the inner catheter was acoustically transparent with 
matched impedance and low attenuation; thereby, allowing for acoustic wave penetration. 
The acoustic impedance match was established by two strategies: 1) water or phosphate-
buffered saline (PBS) was injected into the inner catheter, and 2) the IVUS catheter was 
longer than the outer catheter by 2 – 10 cm (preset length) to avoid the balloon or the outer 
catheter from obstructing the acoustic path. PBS is fill in the inner catheter before 
cannulating, and then the proximal opening is sealed to maintain the PBS for the acoustic 
impedance matching. The IVUS transducer scans the aorta by rotation and pullback inside 
the inner catheter (outer diameter = 1.3 mm). The transducer is navigated by a torque wire. 
The flexibility of IVUS transducer torque wire allows for deployment into the inner catheter. 
The optimal EIS signal was demonstrated by inflating the balloon, allowing the 2-point 
electrode array to be in transient contact with the lumen. The balloon was mounted on the 
outer catheter (outer diameter = 2 mm and inner diameter = 1.7 mm).
2.2 Principles of EIS
EIS is the macroscopic representation of the electric field and current density distribution 
within the specimen being tested (Figure 2). Applying quasi-electrostatic limits to 
Maxwell’s equations, the field distribution can be described as follows [47]:
(1)
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where σ* = σT + jωεT. σT and εT denotes the conductivity and permittivity of the sample, 
respectively, ω the angular frequency, , and φ the voltage distribution. Current 
density, , is calculated with the distribution of electric field, . According to 
Maxwell’s equations, electrical impedance of the sample, Z, is expressed as follows:
(2)
where  denotes the electrode-tissue interface area, and Δφ the voltage difference across the 
two electrodes of the EIS sensor. The resistance and reactance value of the impedance is 
represented as a resister, R, and a capacitor, C (Figure 2A). Contact impedance, ZC, at the 
interface between the electrode and tissue, is not negligible in most cases, and is taken into 
account in the measuring system as previously reported [18, 45].
The electrochemical impedance signal consists of both magnitude and phase information 
(Figure 2D). The low conductivity of oxLDL is the basis for an elevated magnitude in 
impedance in the oxLDL-laden plaques. In contrast, the high conductivity of healthy aorta 
walls exhibits lower impedance magnitude in response to the alternating current (AC). The 
complex impedance of the tissue is expressed as:
(3)
(4)
(5)
where ω is the angular frequency; and ϕ the phase.
Two-point electrode EIS sensor was designed for a high specific measurement with deep 
tissue penetration [41]. The EIS sensor is flexible but non-stretchable, which bends with the 
balloon while keep the sensor dimension and remain robust. Miniature sensor width is 
preferable to minimize the interference to balloon inflation and to enhance the spatial 
specificity. The dimension along the catheter less limited, therefore, the EIS sensor was long 
in this dimension to benefit from high current and low noise. Both electrodes of the EIS 
sensor were 3 mm × 0.3 mm, and were aligned in parallel with 0.3 mm gap in between (inset 
of Figure 1B & Figure 2). The 2-electrode sensor design minimized the number of 
electrodes and maximized the gap, resulting in a deep electromagnetic field penetration into 
tissue. The EIS sensor were made electrical contact to the plaques upon balloon inflation. 
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During EIS assessment, AC current was driven through the plaque while maintaining a 
constant peak voltage. The current was recorded to calculate the electromagnetic impedance 
of the plaque in terms of impedance magnitude and phase (example in Figure 2D). By 
swiping the frequency, and impedance spectrum was acquired.
The flexible EIS sensor was fabricated on the polyimide substrate. First, copper (12 μm) was 
deposited on the polyimide (12 μm) via plated-through-hole (PTH). Subsequently, the 
copper was selectively removed by chemical etching based on lithographically-defined 
pattern using dry film photoresist. A subsequent lamination was done to cover majority of 
the copper area with a second layer of polyimide (12 μm), while leaving the sensor area 
exposed. Finally, Au/Ni (200 nm/20 nm) was immersion coated to the exposed electrodes. 
The polyimide substrate is not stretchable, which ensures the EIS sensor free from cracking 
or discontinuities. The leading wires (30 cm long) were copper layers fabricated together 
with the sensor and covered by the second polyimide layer. The proximal end of the leading 
wires was connected to Series G 300 Potentiostat (Gamry Instruments Inc., PA, USA) for 
EIS measurement.
2.3 Experimental design
EIS measurements were deployed to the ex vivo aortas from NZW rabbit in the presence or 
absence of IVUS guidance. All animal studies were performed in compliance with the 
IACUC protocol approved by the UCLA Office of Animal Research, and were conducted in 
the UCLA translational research imaging center (TRIC) laboratory. Five control rabbits fed 
on a normal chow diet (n=5) and 3 age-matched high-fat fed NZW male rabbits (n=3) were 
analyzed [48–50]. High-fat animals were placed on a 1.5% cholesterol and 6.0% peanut oil 
diet (Harlan Laboratory). After 9 weeks, thoracic aorta sections were dissected for the 
IVUS-guided EIS measurements. The ultrasound transducer rotated in the inner catheter to 
acquire the cross-sectional imaging around the catheter. The ultrasonic A-lines were 
acquired every 0.65 degrees and 550 A-lines were acquired in each frame. After digitization, 
the echo signal was filtered with pass band between 10 MHz and 100 MHz.
After localizing the plaques, the balloon catheter (Figure 1A) was advanced to align with the 
lesion sites. The balloon was inflated at ~2 atm (~ 200 kPa), facilitating the EIS sensors in 
contact with the lumen or lesions for assessing the electrical impedance. The diameter of the 
inflated balloon (6 mm) is slightly larger than the rabbit aorta (within 5 mm). When the EIS 
sensor was pushed against the plaque, the EIS signal changed significantly because highly 
conductive blood was eliminated between the sensor and the plaque. Measurement of 
conductive PBS mimicked [51] the poor contact with blood between sensor and tissue/
plaques (Figure 4). The EIS (especially phase) monitoring and verification process 
guaranteed the contact, and ensured the performance repeatability. Alternating voltage (50 
mV amplitude) was applied to the 2-point electrode, and the current was measured to 
determine the electrical impedance at the frequency sweep from 100 Hz to 300 kHz. Similar 
approach was performed without IVUS guidance. Each individual measurement was 
repeated 5 times.
The IVUS-guided images and EIS measurements were validated by histology. The aortic 
segments were fixed in 4% paraformaldehyde, embedded in paraffin and serially sectioned at 
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5 μm for histological analyses. Lipids were identified by Hematoxylin and Eosin (H&E) 
staining and oxLDL-laden macrophages by F4/80 staining (monoclonal rat anti-mouse 
antibody, Invitrogen).
Statistical analysis quantified the significance of EIS results. Average and standard deviation 
demonstrated the impedance characteristics and the measurement variability. A distinct 
differentiation between oxLDL-laden and lesion-free aortas indicated a preferable 
impedance characterization. Unpaired student’s t-test and analysis of variance [52] with 
multiple comparisons adjustment were performed. A p-value < 0.05 was considered 
statistically significant.
3 Results
3.1 Integrated sensor
A prototype of the integrated sensor consisted of an EIS sensor and an IVUS transducer 
(Figure 3). The two sensors, 2-point electrode and ultrasonic transducer, were fabricated 
individually, followed by integration for the catheter-based deployment to assess oxLDL-
laden plaques. The IVUS transducer [46] was mounted on a rotational shaft to generate 
radial cross-sectional images of the aortas. Interference between the two elements was 
minimized by separating them spatially (Figure 3A). The IVUS transducer was positioned in 
the acoustic image window distal to the balloon and EIS sensor.
3.2 Intravascular ultrasound imaging
Intravascular ultrasound imaging visualized the topography of the aorta and identified the 
endoluminal atherosclerotic lesions. The plaques were identified by ultrasound due to their 
distinct scattering characteristics (IVUS imaging results in Figure 4). In the IVUS-guided 
measurement, the EIS sensor was steered to the endoluminal sites to assess the eccentric 
plaques present in the thoracic aorta. In contrast, random EIS measurements were performed 
without the IVUS-guidance to compare variability and reproducibility.
3.3 Electrochemical impedance spectroscopy
In both the IVUS guided- and non-guided EIS measurements, the mean values of the 
impedance magnitude (kΩ) in oxLDL-laden plaque were elevated as compared to the control 
(Figure 4A & B). The non-IVUS-guided EIS harbored a wide range of magnitude values, 
with the lower limits overlapping with those of control (Figure 4A), likely from 
misalignment with the plaque. As a random measurement, EIS at Sites 2 and 3 aligned with 
the lesion, resulting distinct impedance magnitude, whereas EIS measurement at Site 1 
(lesion free) was indistinct from the control. In the case of IVUS-guided measurement, the 
EIS measurements were aligned with the lesions, resulting in increased frequency-dependent 
separation from those of control across the entire frequency range (100 Hz – 300 kHz) 
(Figure 4B).
In addition to the impedance magnitude, the phase (ϕ) spectra provided an alternative 
detection for the oxLDL-laden lesions (Figure 4C & D). As supported by Eq. (5), the phase 
of all the measurements overlapped at high frequencies (> 20 kHz). In the random 
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measurements, the phases of lesion sites overlapped with the control (Figure 4C), while in 
the guided measurement the lesion sites were distinct at < 15 kHz (Figure 4D).
Statistical analysis demonstrated the EIS measurements with and without IVUS guidance 
(Figure 5). In the case without IVUS guidance, impedance magnitude (kΩ) at Sites 2 & 3 
was distinct from control (p < 0.0001 for either A or B), whereas measurement at Site 1 was 
insignificant (p < 0.2). EIS measurements were statistically insignificant considering all 
results (Figure 5A). IVUS-guided EIS measurements demonstrated statistically significant 
differences with the added advantage of smaller data spread in a given condition leading to 
smaller standard deviations (average of 0.54 kΩ for guided and 1.04 kΩ for non-guided 
measurements) (Figure 5A). Phase delay, an alternative measure derived from EIS, 
demonstrated similar trends (Figure 5B). Significant statistics were observed at < 20 kHz 
with IVUS-guidance, whereas insignificance exhibited throughout the frequency range 
without IVUS-guidance except 2 – 15 kHz range.
4 Discussion
The novelty of the current work resides in the integrated sensor design to enable IVUS-
guided EIS assessment of metabolically unstable plaque. The double-layer catheter allowed 
for the flexible 2-point electrode to affix to the balloon anchored to the outer catheter while 
the rotating ultrasonic transducer was deployed to the inner catheter. The imaging window 
distal to the balloon provided matched acoustic impedance, enabling the high-frequency 
transducer (45 MHz) to visualize the vessel lumen and 2-point electrode to align with the 
plaques. Thus, we introduced the first IVUS-guided EIS sensor to detect intraplaque oxLDL 
with reduced standard deviation (from 1.04 to 0.54 kΩ on average for magnitude) and 
increased statistical significance (from p < 0.07 to p < 0.0001 for magnitude) compared to 
non-guided results [15, 41, 53]. Prior to deployment in vivo, the sensors were heparinized in 
1000 U/ml heparin to minimize adverse interactions between the sensor and blood. Our prior 
in vivo EIS measurements have demonstrated signal stability in the presence of blood 
(Supplementary file).
The integrated sensor strategy paved the way to diagnose vulnerable plaques to predict acute 
coronary events or stroke [17, 54]. The non-guided EIS measurements require repeated trials 
at multiple sites in need of deflating and re-inflating of the balloon, prolonging procedure 
time with possible fluoroscopy X-rays exposure [55], whereas the IVUS imaging prior to 
EIS measurement visualizes the anatomy to enable precise alignment with lesions for EIS 
measurement by single inflation. Statistically significant results were obtained by the IVUS-
guided EIS measurement (p < 0.0001 for magnitude and p < 0.005 for phase within 15 kHz), 
whereas measurements without the guidance reduced the significance (p < 0.07 for 
magnitude and p < 0.4 within 15 kHz) (Figure 5). Without guidance, measurement at 
random sites caused large variation and low significance in existing publications as well, 
where lower boundary of lesion sites overlapped the upper boundary of control [15, 41].
Despite significant consistency and reliability, the current design is subjected to 
improvement. To establish a simultaneous IVUS guided EIS measurement, the inner, outer 
catheters, as well as the gap between them have to be acoustically transparent. Water instead 
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of air would be used to inflate the balloon. Currently, the outer catheter is not transparent 
enough for an acoustic window of the ultrasonic transducer. In addition, fractional flow 
reserve (FFR) [56, 57] can be incorporated for the future design. A triad of intravascular 
shear stress (ISS) and electrochemical impedance spectroscopy (EIS) would allow initial 
identification by disturbed shear, followed by visualization by IVUS, and then 
electrochemical characterization by EIS, providing patient-specific intervention. 
Additionally, the current 2-electrode EIS provide certain quantitative evaluation of the 
plaque severity [41]. Nevertheless, this sensor does not generate detailed quantitative 
information, such as plaque morphology and 3-dimensional oxLDL concentration. 
Electrochemical impedance tomography using 32 electrodes are being developed in our 
group for detailed quantitation.
Percutaneous coronary intervention (PCI) serves as standard of care clinically. Using the 
minimally invasive technique, the integrated sensor evaluates plaque vulnerability when 
plaques are detected by non-invasive techniques. This integrated sensor provides a reliable 
and consistent assessment of oxLDL laden plaques, and estimate of potential clinical events 
such as coronary syndromes or stroke [17, 54]. Compared to standard PCI which blocks the 
blood flow for about 10 – 400 seconds (usually within 90 seconds) [58–60], this integrated 
sensor scans the spectrum at 40 frequencies within 60 seconds. In actual measurement, 
impedance measurement at one or two frequencies (for example, 100 kHz) is sufficient to 
distinguish vulnerable plaques from healthy endothelium, which can be accomplished with a 
few seconds. Compared with non-guided EIS measurements that have to repeat 
measurements at various sites (about 5 minutes).
5 Conclusion
We introduced integrated IVUS and EIS sensors for an accurate and reliable strategy to 
characterize intraplaque oxLDL. The IVUS imaging window and the EIS sensor are 
spatially separated in the double layer catheter design for an effective acoustic window and 
elimination of interference between the two sensors. The IVUS-guided EIS ensured 
specifically targeted measurements at the lesion sites, and consequently resulted in high 
consistency and significance of the electrical impedance. Thus, the dual sensor strategy 
holds the potential for precision medicine.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
(A) Conceptual scheme depicts the deployment of the integrated sensor consisting of an EIS 
sensor and an IVUS transducer to assess lipid-rich plaques. The IVUS sensor visualizes the 
aorta lumen, and the imaging information provides guidance for EIS characterization of the 
plaques by aligning the EIS sensor (2-point electrode) at the plaque. PBS: Phosphate-
buffered saline solution. (B) The design of the integrated sensor highlights the mechanism 
for IVUS-guided EIS measurement. The IVUS transducer is positioned inside the inner 
catheter (ID: 1 mm, OD: 1.3 mm) with an imaging window of 2 cm to 10 cm. The EIS 
sensor is affixed to the balloon, which is anchored to the outer catheter (ID: 1.7 mm, OD: 2 
mm). External pump generates air pressure to inflate or deflate the balloon, ranging from 2.3 
mm to 6 mm in diameter.
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Figure 2. 
(A) Schematic representation of the equivalent circuit for EIS measurement. (B) In an EIS 
system, the EIS sensor (exposed electrode) is attached to the specimen (e.g. aorta covered by 
plaques). (C) The impedance is recorded by an impedance analyzer, as illustrated by (D) the 
current-voltage (I–V) curve to provide both magnitude and phase delay.
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Figure 3. 
A prototype of the integrated sensor. (A) The photograph of the integrated sensor 
highlighted the relative position of the EIS sensor and the ultrasonic transducer. (B) Zoom-in 
of the EIS sensor illustrated the polyimide substrate for flexibility. (C) Zoom-in of the IVUS 
transducer inside the inner catheter and its frequency responses.
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Figure 4. 
Performances of the integrated transducer were demonstrated by comparing random (non-
guided) and guided-measurements. Without the guidance, the EIS measurements at Site 1 
missed the lesions (red arrow). With the IVUS guidance, EIS measurement sites were 
aligned with Sites 1, 2, and 3 (red, green, and blue arrow). (A) and (B) illustrated EIS 
measurement in terms of impedance magnitude, (C) and (D) the phase spectra. (A) 
Frequency-dependent impedance (kΩ) increased between 100 Hz to 300 kHz in the oxLDL-
laden aorta (red, green, and blue) versus the lesion-free aorta (control, black). (B) With the 
IVUS guidance, the frequency-dependent impedance (red, green, and blue arrows) 
significantly increased between 100 Hz to 300 kHz as compared to the control (black). (C) 
The phase spectrum was indistinct in the random measurements from 100 Hz to 300 kHz. 
(D) With the guidance, the phase was distinct from the control at < 15 kHz.
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Figure 5. 
(A) Statistical analysis of the magnitude measurements. (B) The random measurements 
resulted in insignificant result (p < 0.4) while the guided measurement resulted in significant 
result (p < 0.005) at < 15 kHz). At high frequencies (> 20 kHz), even guided measurements 
were statistically insignificant.
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